SSIEM 2023

Rare Complication of Hereditary Tyrosinemia Type 1: Neurogenic Crisis

Fehime Erdem 1 Havva Yazici 1 Merve Yoldas Celik 1 Ayse Yuksel Yanbolu 1 Pinar Yazici Ozkaya 2 Ebru Canda 1 Sema Kalkan Ucar 1 Bulent Karapinar 2 Mahmut Coker 1
1Ege University Faculty of Medicine, Department of Pediatrics, Division of Metabolism and Nutrition, Turkiye
2Ege University Faculty of Medicine, Department of Pediatrics, Division of Pediatric Intensive Care, Turkiye

renal tubular dysfunction, and growth retardation. Neurogenic crisis accompanied by rare and life-threatening encephalopathy, seizure, severe abdominal pain, and respiratory problems may occur in patients who are not treated adequately to provide disease control with nitisinone, supportive treatments, phenylalanine and tyrosine-restricted diet.

We aimed to share the diagnosis, clinical and follow-up information for this rare and life-threatening complication.

Methods: Six (15%) of the 38 tyrosinemia cases in our follow-up showed neurogenic crisis. Clinical, laboratory, and therapeutic data related to neurogenic crises were retrospectively evaluated from their medical records.

Results: The mean age at diagnosis was 8.3 ± 1.8 months (7−11), and nitisinone and phenylalanine-tyrosine restricted diet were started in all cases at the time of diagnosis. The mean age of development of neurogenic crisis was 84 ± 46 months (38−160) and the patients interrupted nitisinone treatment and diet mean was 23±17 days (3−45).

The first symptom of all cases was abdominal pain, altered consciousness, and 5 cases had seizures. All cases were encephalopathic and hypertensive at the first admission. Laboratory results showed hyponatremia in 4 cases, urine succinylacetone in 2 cases, blood succinyl acetone in 4 cases, and urinary aminolevulinic acid levels in 5 cases were high. Two cerebral MRIs revealed the presence of PRESS. Tracheostomy was required in one case due to severe respiratory failure.

Discussion/conclusion: In untreated patients, increased delta aminolevulenic acid levels at the end of porphobilinogen synthase blooms cause severe porphyry-like abdominal pain. Although there is no clear laboratory data for this life-threatening clinical event, the most important diagnostic finding is clinical, nitisinone treatment and supportive treatment should be started urgently.